H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, trend analysis, applicable previous investigation(s), sample (if available), and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a damaged infusion set was confirmed but the exact cause remains unknown.The product returned for evaluation was a one 22ga x 0.75" powerloc safety infusion set.The returned product sample was evaluated and the needle was observed to be bent near the exit site from the housing.An attempt to advance the safety was successful; however, resistance was encountered when passing the safety over the bent region of the needle.The following observations were noted during the sample evaluation: the sample appeared free of obvious use residue the tip of the needle bevel appeared unremarkable.Based on the evidence provided with the returned sample it is unknown when or how the bend occurred in the needle.Damage to the needle could have occurred at the manufacturing facility, during shipping, during use, or during storage of the product, and no evidence was observed which supported a specific root cause of the event.H3 other text : evaluation findings are in section h.11.
|